Kerscher M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, Dirschka T, Altmeyer P
Department of Dermatology, Ruhr-University Bochum, Germany.
J Am Acad Dermatol. 1998 Jan;38(1):21-6. doi: 10.1016/s0190-9622(98)70533-x.
For treatment of localized scleroderma numerous treatments, including ones with potentially hazardous side effects, are currently used with only limited success.
We attempted to determine the efficacy of low-dose UVA1 irradiation in patients with severe localized scleroderma.
Patients were irradiated with 20 J/cm2 UVA1 for 12 weeks (total number of treatments: 30; cumulative UVA1 dose: 600 J/cm2).
Low-dose UVA1 irradiation induced significant clinical improvement (clearance of > 80% of lesions) in 18 of 20 patients. Clearance was documented by clinical score as well as by 20 MHz ultrasound and histopathologic analysis.
Low-dose UVA1 phototherapy can be highly effective for sclerotic plaques, even in patients with advanced localized scleroderma and with lesions rapidly evolving despite conventional therapy.
对于局限性硬皮病的治疗,目前使用了多种治疗方法,包括一些具有潜在有害副作用的方法,但效果有限。
我们试图确定低剂量UVA1照射对重度局限性硬皮病患者的疗效。
患者接受20 J/cm²的UVA1照射,持续12周(治疗总次数:30次;UVA1累积剂量:600 J/cm²)。
20例患者中有18例经低剂量UVA1照射后临床症状显著改善(病变清除率>80%)。临床评分、20 MHz超声及组织病理学分析均证实了病变的清除。
低剂量UVA1光疗对硬化斑块可能非常有效,即使是晚期局限性硬皮病患者,且尽管接受了传统治疗,病变仍在快速进展。